Recent 8-K filings for KYNB

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:05 UTC earnings item 2.02item 9.01

  Kyntra Bio reports Q1 2026 net loss of $15.1M ($3.74/share) and cash runway into 2028

source · KYNB on sec.gov